Column agglutination technology: the antiglobulin test

Area of Science:

• Transfusion Medicine
• Immunology
• Clinical Pathology

Background:

• Conventional blood typing and antibody screening methods can be time-consuming and subjective.
• The need for efficient and objective diagnostic tools in transfusion services is critical.
• Existing methods like tube tests and low-ionic-strength methods have limitations in speed and objectivity.

Purpose of the Study:

• To introduce and evaluate a new blood typing and screening system based on column agglutination technology.
• To compare the performance of this new system against conventional tube tests and low-ionic-strength methods.
• To assess the efficiency and objectivity of the column agglutination technology for detecting red cell antibodies.

Main Methods:

• Development of a new test system utilizing glass bead microparticles in a microcolumn.
• Incorporation of anti-human globulin reagents into the diluent for direct testing.
• Screening of 228 serum and plasma samples for red cell antibodies using column agglutination technology, tube tests, and low-ionic-strength methods.

Main Results:

• Column agglutination technology demonstrated 94% agreement with tube tests after initial testing, increasing to 97% after repeat testing.
• The new system effectively traps agglutinated red blood cells within the glass bead matrix during centrifugation.
• Unagglutinated cells form a distinct pellet, allowing for clear and objective result interpretation.

Conclusions:

• Column agglutination technology offers a reliable and objective alternative for blood typing and antibody screening.
• This method significantly reduces test time by eliminating the need for red blood cell washing.
• The ease of performance and enhanced objectivity make it a valuable advancement in transfusion medicine.